-
1.发明授权Benzothiazepine and benzothiazepine derivatives with ileal bile acid transport (IBAT) inhibotory activity for the treatment hyperlipidaemia 有权苯并硫氮嗪和苯并硫氮杂衍生物与回肠胆汁酸转运（IBAT）的抑制作用，用于治疗高脂血症公开(公告)号：US07132416B2
公开(公告)日：2006-11-07
申请号：US10488870
申请日：2002-09-05
申请人： Ingemar Starke , Mikael Ulf Johan Dahlstrom , David Blomberg , Suzanne Alenfalk , Tore Skjaret , Malin Lemurell
发明人： Ingemar Starke , Mikael Ulf Johan Dahlstrom , David Blomberg , Suzanne Alenfalk , Tore Skjaret , Malin Lemurell
IPC分类号： C07D281/02 , A61K38/05 , A61K38/06
CPC分类号： C07D417/12 , C07D285/36
摘要： The present invention relates to compounds of formula (I) wherein Rv, R1, R2, Rx, Ry, M, Rz, v, R3, R4, R5 and R6 are as defined within; pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and their use as ileal bile acid transport (IBAT) inhibitors for the treatment of hyperlipidaemia. Processes for their manufacture and pharmaceutical compositions containing them are also described.
摘要翻译： 本发明涉及式（I）的化合物，其中R 1，R 2，R 2，R x，X 2， R 1，R 2，R 3，R 4，R 4，R 4， 5＆lt; 6＆gt;和＆lt; 6＆gt;的定义如下： 药学上可接受的盐，溶剂合物，这些盐的溶剂合物和前药，以及它们作为回肠胆汁转运（IBAT）抑制剂用于治疗高脂血症的用途。 还描述了其制备方法和含有它们的药物组合物。
-
2.发明授权公开(公告)号：US07192947B2
公开(公告)日：2007-03-20
申请号：US10518010
申请日：2003-06-10
IPC分类号： A61P3/06 , A61K31/554 , C07D281/10
CPC分类号： C07K5/06078 , A61K38/00
摘要： The present invention relates to compounds of formula (I): (wherein variable groups are as defined within) pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and their use as ileal bile acid transport (IBAT) inhibitors for the treatment of hyperlipidaemia. Process for their manufacture and pharmaceutical compositions containing them are also described
摘要翻译： 本发明涉及式（I）的化合物：（其中可变基团如本文所定义）其药学上可接受的盐，溶剂合物，这些盐的溶剂合物和前药以及它们作为回肠胆汁转运（IBAT）抑制剂用于治疗 高脂血症 还描述了其制备方法和含有它们的药物组合物
-
3.发明申请Benzothiazepine and benzothiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia 有权具有回肠胆汁酸运输（ibat）抑制活性的苯并硫氮嗪和苯并硫氮因衍生物用于治疗高脂血症公开(公告)号：US20050038009A1
公开(公告)日：2005-02-17
申请号：US10488870
申请日：2002-09-05
申请人： Ingemar Starke , Mikael Dahlstrom , David Blomberg , Suzanne Alenfalk , Tore Skjaret , Malin Lemurell
发明人： Ingemar Starke , Mikael Dahlstrom , David Blomberg , Suzanne Alenfalk , Tore Skjaret , Malin Lemurell
IPC分类号： A61K20060101 , A61K31/192 , A61K31/397 , A61K31/40 , A61K31/505 , A61K31/554 , A61K31/695 , A61K31/785 , A61P20060101 , A61P3/06 , A61P7/02 , A61P9/00 , A61P9/04 , A61P9/06 , A61P9/08 , A61P9/10 , A61P17/02 , A61P31/00 , A61P43/00 , C07D20060101 , C07D281/02 , C07D281/10 , C07D285/36 , C07D417/12 , C07F7/10 , C07K20060101 , C07D291/08
CPC分类号： C07D417/12 , C07D285/36
摘要： The present invention relates to compounds of formula (I) wherein Rv, R1, R2, Rx, Ry, M, Rz, v, R3, R4, R5 and R6 are as defined within; pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and their use as ileal bile acid transport (IBAT) inhibitors for the treatment of hyperlipidaemia. Processes for their manufacture and pharmaceutical compositions containing them are also described.
摘要翻译： 本发明涉及式（I）化合物，其中R 1，R 2，R 2，R x，R y，M，R z，v，R 3， R 4，R 5和R 6如上所定义; 药学上可接受的盐，溶剂合物，这些盐的溶剂合物和前药，以及它们作为回肠胆汁转运（IBAT）抑制剂用于治疗高脂血症的用途。 还描述了其制备方法和含有它们的药物组合物。
-
4.发明申请Peptides derivatives comprising thiazepine group for the treatment of hyperlipidermic conditions 有权含有硫氮杂基团的肽衍生物用于治疗高脂皮质病症公开(公告)号：US20050222120A1
公开(公告)日：2005-10-06
申请号：US10518010
申请日：2003-06-10
IPC分类号： A61K38/00 , A61P3/06 , A61P9/10 , C07K5/065 , A61K31/554 , C07D281/08
CPC分类号： C07K5/06078 , A61K38/00
摘要： The present invention relates to compounds of formula (I): (wherein variable groups are as defined within) pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and their use as ileal bile acid transport (IBAT) inhibitors for the treatment of hyperlipidaemia. Process for their manufacture and pharmaceutical compositions containing them are also described.
摘要翻译： 本发明涉及式（I）的化合物：（其中可变基团如本文所定义）其药学上可接受的盐，溶剂合物，这些盐的溶剂合物和前药以及它们作为回肠胆汁转运（IBAT）抑制剂用于治疗 高脂血症 还描述了其制备方法和含有它们的药物组合物。
-
5.发明授权Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them 有权苯并噻二嗪衍生物，其制备方法和含有它们的药物组合物公开(公告)号：US07238684B2
公开(公告)日：2007-07-03
申请号：US10511984
申请日：2003-04-23
申请人： Ingemar Starke , Mikael Ulf Johan Dahlstrom , Mats Peter Nordberg , Suzanne Alenfalk , Andreas Christer Wallberg , Stig Jonas Bostrom
发明人： Ingemar Starke , Mikael Ulf Johan Dahlstrom , Mats Peter Nordberg , Suzanne Alenfalk , Andreas Christer Wallberg , Stig Jonas Bostrom
IPC分类号： C07D285/36 , A61K31/554
CPC分类号： C07D285/36
摘要： The present invention relates to compounds of formula (I): wherein Rv, R1, R2, Rx, Ry, R3, R4, R5, R6, Rz and v are as defined within; pharmaceutically acceptable salts, solvates, solvates or such salts and prodrugs thereof and their use as ileal bile acid transport (IBAT) inhibitors for the treatment of hyperlipidaemia. Processes for their manufacture and pharmaceutical compositions containing them are also described.
摘要翻译： 本发明涉及式（I）化合物：其中R 1，R 2，R 2，R x， R S，R 3，R 3，R 4，R 5，R 6， V S，R z如上所定义; 药学上可接受的盐，溶剂合物，溶剂化物或其盐和前药，以及它们作为回肠胆汁酸转运（IBAT）抑制剂用于治疗高脂血症的用途。 还描述了其制备方法和含有它们的药物组合物。
-
公开(公告)号：US07192946B2
公开(公告)日：2007-03-20
申请号：US10488540
申请日：2002-08-30
申请人： Ingemar Starke , Mikael Ulf Johan Dahlstrom , David Blomberg , Suzanne Alenfalk , Peter Nordberg , Andreas Christer Wallberg , Stig Jonas Bostrom
发明人： Ingemar Starke , Mikael Ulf Johan Dahlstrom , David Blomberg , Suzanne Alenfalk , Peter Nordberg , Andreas Christer Wallberg , Stig Jonas Bostrom
IPC分类号： A61P3/06 , A61K31/554 , C07D281/10
CPC分类号： C07D417/12 , C07D281/10
摘要： The present invention relates to compounds of formula (I), wherein variable groups are as defined within; pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and their use as ileal bile acid transport (IBAT) inhibitors for the treatment of hyperlipidaemia. Processes for their manufacture and pharmaceutical compositions containing them are also described
摘要翻译： 本发明涉及式（I）化合物，其中可变基团如本文所定义; 药学上可接受的盐，溶剂合物，这些盐的溶剂合物和前药，以及它们作为回肠胆汁转运（IBAT）抑制剂用于治疗高脂血症的用途。 还描述了其制备方法和含有它们的药物组合物
-
公开(公告)号：US20050143368A1
公开(公告)日：2005-06-30
申请号：US10511984
申请日：2003-04-23
申请人： Ingemar Starke , Mikael, Ulf, Johan Dahlstrom , Mats, Peter Nordberg , Suzanne Alenfalk , Andreas, Christer Wallberg , Stig, Jonas Bostrom
发明人： Ingemar Starke , Mikael, Ulf, Johan Dahlstrom , Mats, Peter Nordberg , Suzanne Alenfalk , Andreas, Christer Wallberg , Stig, Jonas Bostrom
IPC分类号： C07D239/42 , A61K31/255 , A61K31/40 , A61K31/505 , A61K31/554 , A61K45/00 , A61P1/12 , A61P3/06 , A61P3/08 , A61P7/02 , A61P9/00 , A61P9/04 , A61P9/06 , A61P9/10 , A61P9/14 , A61P29/00 , A61P31/00 , A61P41/00 , A61P43/00 , C07D207/34 , C07D285/36 , C07D417/12 , A61K31/225 , A61K31/366 , A61K31/401
CPC分类号： C07D285/36
摘要： The present invention relates to compounds of formula (1): wherein Rv, R1, R2, Rx, Ry, R3, R4, R5, R6, Rz and v are as defined within; pharmaceutically acceptable salts, solvates, solvates or such salts and prodrugs thereof and their use as ileal bile acid transport (IBAT) inhibitors for the treatment of hyperlipidaemia. Processes for their manufacture and pharmaceutical compositions containing them are also described.
摘要翻译： 本发明涉及式（1）的化合物：其中R 1，R 2，R 2，R x， R S，R 3，R 3，R 4，R 5，R 6， V S，R z如上所定义; 药学上可接受的盐，溶剂合物，溶剂化物或其盐和前药，以及它们作为回肠胆汁酸转运（IBAT）抑制剂用于治疗高脂血症的用途。 还描述了其制备方法和含有它们的药物组合物。
-
公开(公告)号：US08067584B2
公开(公告)日：2011-11-29
申请号：US10546005
申请日：2004-02-23
申请人： Ingemar Starke , Suzanne Alenfalk , Mats Peter Nordberg , Mikael Ulf Johan Dahlstrom , Stig Jonas Bostrom , Malin Anita Lemurell , Andreas Christer Wallberg
发明人： Ingemar Starke , Suzanne Alenfalk , Mats Peter Nordberg , Mikael Ulf Johan Dahlstrom , Stig Jonas Bostrom , Malin Anita Lemurell , Andreas Christer Wallberg
IPC分类号： C07D281/10 , A61K31/554
CPC分类号： C07D281/10 , C07D337/08
摘要： Compounds of formula: (1) pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and their use as ileal bile acid transport (IBAT) inhibitors for the treatment of hyperlipidaemia are described. Processes for their manufacture and pharmaceutical compositions containing them are also described.
摘要翻译： 描述了下列化合物：（1）其药学上可接受的盐，溶剂化物，这些盐及其前体药物的溶剂合物及其作为回肠胆汁酸转运（IBAT）抑制剂用于治疗高脂血症的用途。 还描述了其制备方法和含有它们的药物组合物。
-
公开(公告)号：US20060094884A1
公开(公告)日：2006-05-04
申请号：US10546005
申请日：2004-02-23
申请人： Ingemar Starke , Suzanne Alenfalk , Mats Nordberg , Mikael Dahlstrom , Stig Bostrom , Malin Lemurell , Andreas Wallberg
发明人： Ingemar Starke , Suzanne Alenfalk , Mats Nordberg , Mikael Dahlstrom , Stig Bostrom , Malin Lemurell , Andreas Wallberg
IPC分类号： C07D337/12
CPC分类号： C07D281/10 , C07D337/08
摘要： Compounds of formula: (1) pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and their use as ileal bile acid transport (IBAT) inhibitors for the treatment of hyperlipidaemia are described. Processes for their manufacture and pharmaceutical compositions containing them are also described.
摘要翻译： 描述了下列化合物：（1）其药学上可接受的盐，溶剂化物，这些盐及其前体药物的溶剂合物及其作为回肠胆汁酸转运（IBAT）抑制剂用于治疗高脂血症的用途。 还描述了其制备方法和含有它们的药物组合物。
-
-
-
-
-
-
-
-
搜索结果
9 条记录 (耗时 0.029 秒)
